El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

ijerph-20-00405.pdf (4.47 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2022-12-27

Llicència de publicació

cc by (c) Clèries Soler, Ramon et al., 2022
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/193134

Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.3390/ijerph20010405

Resum

Mortality from cardiovascular disease (CVD), second tumours, and other causes is of clinical interest in the long-term follow-up of breast cancer (BC) patients. Using a cohort of BC patients (N = 6758) from the cancer registries of Girona and Tarragona (north-eastern Spain), we studied the 10-year probabilities of death due to BC, other cancers, and CVD according to stage at diagnosis and hormone receptor (HR) status. Among the non-BC causes of death (N = 720), CVD (N = 218) surpassed other cancers (N = 196). The BC cohort presented a significantly higher risk of death due to endometrial and ovarian cancers than the general population. In Stage I, HR- patients showed a 1.72-fold higher probability of all-cause death and a 6.11-fold higher probability of breast cancer death than HR+ patients. In Stages II-III, the probability of CVD death (range 3.11% to 3.86%) surpassed that of other cancers (range 0.54% to 3.11%). In Stage IV patients, the probability of death from any cancer drove the mortality risk. Promoting screening and preventive measures in BC patients are warranted, since long-term control should encompass early detection of second neoplasms, ruling out the possibility of late recurrence. In patients diagnosed in Stages II-III at an older age, surveillance for preventing late cardiotoxicity is crucial.

Matèries

Càncer de mama, Malalties cardiovasculars, Mortalitat

Matèries (anglès)

Breast cancer, Cardiovascular diseases, Mortality

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

CLÈRIES SOLER, Ramon, AMEIJIDE, Alberto, BUXÓ, Maria, VILARDELL, Mireia, MARTÍNEZ, José miguel, FONT, Rebeca, MARCOS GRAGERA, Rafael, PUIGDEMONT, Montse, VIÑAS, Gemma, CARULLA, Marià, ESPINÀS PIÑOL, Josep alfons, GALCERAN, Jaume, IZQUIERDO, Ángel, BORRÀS ANDRÉS, Josep maria. Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain. _International Journal of Environmental Research and Public Health_. 2022. Vol. 20, núm. 1, pàgs. 405. [consulta: 24 de desembre de 2025]. ISSN: 1660-4601. [Disponible a: https://hdl.handle.net/2445/193134]

Exportar metadades

JSON - METS

Compartir registre